Cargando…
The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients
BACKGROUND: Bladder cancer (BCa) shows its potential immunogenity in current immune-checkpoint inhibitor related immunotherapies. However, its therapeutic effects are improvable and could be affected by tumor immune microenvironment. Hence it is interesting to find some more prognostic indicators fo...
Autores principales: | Jiang, Liren, Chen, Siteng, Pan, Qi, Zheng, Jun, He, Jin, Sun, Juanjuan, Han, Yaqin, Yang, Jiji, Zhang, Ning, Fu, Guohui, Gao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210750/ https://www.ncbi.nlm.nih.gov/pubmed/35725413 http://dx.doi.org/10.1186/s12885-022-09783-y |
Ejemplares similares
-
A Novel Nomogram Based on Machine Learning-Pathomics Signature and Neutrophil to Lymphocyte Ratio for Survival Prediction of Bladder Cancer Patients
por: Chen, Siteng, et al.
Publicado: (2021) -
Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer
por: Chen, Siteng, et al.
Publicado: (2021) -
A Novel m(6)A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell Carcinoma
por: Chen, Siteng, et al.
Publicado: (2021) -
Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer
por: Xiong, Hui, et al.
Publicado: (2021) -
A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer
por: Chen, Siteng, et al.
Publicado: (2019)